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Viral loada b s t r a c t
The prevalence of hepatitis C virus (HCV) is highest in Egypt compared to other countries. Nucleic acid
amplification test (NAT) allows detection of HCV early during the course of infection. Unfortunately,
NAT is more expensive than ELISA, thus its routine use as a screening tool for blood products or in clinical
practice is quite limited. The aim of this study was to compare two common RT-PCR methods, TaqMan
probe technique and SYBR Green method in quantitative detection of HCV RNA for diagnosis and follow
up of HCV patients. Among the recruited 220 HCV patients, 154 (70%) were HCV-RNA positive by both the
techniques, while 24 (10.9%) were negative by both techniques. On the other hand, 40 (18.2%) cases were
HCV RNA positive only by SYBR Green technique, and 2 (0.9%) only by TaqMan probe technique. Forty
(20.4%) of the 196 chronic HCV cases were HCV-RNA positive by SYBR Green but negative by TaqMan
probe technique.
Conclusion: This method is useful for rapid qualitative detection of HCV infection and particularly suit-
able for routine diagnostic applications.
 2017 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hepatitis C virus (HCV) causes both acute and chronic infection.
Acute HCV infection is usually asymptomatic, and very rarely
associated with a life-threatening condition. About 15–45% of the
infected individuals naturally clear the virus within six months
of infection without any medical intervention, and in only 55–
85% of individuals the infection takes into chronic form. In chronic
HCV infection, the risk of liver cirrhosis is 15–30% within 20 years.
At a global level, 130–150 million people are having chronic
hepatitis C infection.1 Since most countries do not have complete
data, this estimate is based on weighted average for regions rather
than individual countries. Its lowest prevalence is in the United
Kingdom and Scandinavia, while the highest has been reported
(15–20%) from Egypt.2
The tests that can detect antibody to HCV (anti-HCV) were first
licensed by the Food and Drug Administration (FDA) in 1990. Sincethen, anti-HCV tests are being widely used for clinical diagnosis
and screening of asymptomatic persons.3
CDC has recommended that a person should be considered to
have serologic evidence of HCV infection only after the positive
result of an anti-HCV screening-test has been verified by a more
specific serologic test (e.g., recombinant immunoblot assay (RIBA)
or nucleic acid test (NAT).4
The assays for antiviral antibodies, cannot detect an early HCV
infection; this leads to false negative result. Nucleic acid amplifica-
tion tests (NAT) allow detection of HCV much earlier in the course
of infection, often as early as 11 days. These tests can also differen-
tiate between active and resolved infection. In addition, NAT has a
very high sensitivity and specificity, thus it can be used as an inde-
pendent method for confirming HCV infection.5–7 Unfortunately
NAT is more expensive than ELISA, thus its routine use as a screen-
ing tool for blood products or in clinical practice is limited. Several
methods, such as branched DNA (signal amplification),
transcription-mediated amplification and PCR, are currently in
use for detection of HCV RNA.8
Conventional PCR uses gel electrophoresis to identify the ampli-
fication product that takes several hours. A cross-contamination of
HCV nucleic acid between the specimens may occur. Recently, PCR
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real-time detection of products during the amplification. This com-
bination allows convenient detection of PCR products and obviates
the need for extensive assessment procedures.9
HCV RT-PCR per sample costs in different private laboratories in
Egypt range from $25 to $40, while SYBR Green I assay costs $15 to
obtain the same results.
SYBR Green I when binds to the minor groove of double-
stranded deoxyribonucleic acid (dsDNA) emits fluorescence
1000-fold greater than it’s free in solution. Therefore, the increas-
ing amount of dsDNA present in the reaction tube lead to the
greater amount of bound dyes and increasing fluorescent signal
from SYBR Green I. This method is relatively cost benefit and easy
to use. Specificity is the most important concern with the usage of
any of these non-specific dsDNA-binding dyes. Non-specific prod-
ucts reflected in dissociation curve of the amplified product as
non-specific peaks.7
The aim of this study was to compare two common RT-PCR
methods, TaqMan probe technique and SYBR Green method in
quantitative detection of HCV RNA for diagnosis and follow up of
HCV patients.2. Materials and methods
Two hundred and twenty consecutive HCV patients, naïve or
under treatment, were selected from the outpatient clinics of the
Medical Research Institute, Alexandria University. Exclusion crite-
ria included patients with renal, cardiac, neoplastic disease,
immunological disorders. Each patient responded to a question-
naire to collect demographic data such as age and sex.
The study protocol was approved by the Institutional Review
Board and Ethics Committee of the Medical Research Institute,
Alexandria University. All patients signed an informed consent
form.2.1. RNA extraction
RNA extraction was carried out from 140 mL of serum specimens
using a QIAamp viral RNA kit (QIAGEN, Valencia, CA) following the
manufacturer’s instructions. The extract was divided into two
tubes; one for the TaqMan technique and the other stored at
20 C to be used for SYBR Green technique (which was performed
immediately after the TaqMan PCR within 3 hoursto avoid RNA
degradation).2.2. Determination of viral load using TaqMan technique
The extracted RNA (10 lL) was amplified by using HCV Qiagen
kit (Artus, QS-RGQ(72) ref. 4518366 HCV PCR kit). RT-PCR reac-
tions were performed in a final volume of 25 lL using the PCR
MX3000 Stratagene system (Applied Biosystems Inc., Foster city,
California, USA).
For a PCR reaction the following thermal profile was employed:
50 C for 30 min (reverse transcriptase step) followed by AmpliTaq
activation step at 95 C for 15 min, followed by a three-step PCR
protocol, 95 C for 30 s and followed by annealing at 50 C for 1
min and extension at 72 C for 30 s for 40 cycles with end point flu-
orescence detection.
For determination of the viral load, Ct value was used against
standard curve to determine the viral load. Four standard HCV
copy DNA molecules (provided by the manufacturer) were pro-
cessed as described and the standard curve was plotted.2.3. Detection of HCV RNA by SYBR Green technique
SYBR Green I real-time RT-PCR was carried out using Sigma-
Fermentas one step RT PCR kit in a 25 lL reaction volume that con-
tained; 12.5 mL SYBR Green master mix, 1.25 mL RT enhancer, 0.3 mL
Forward primer (k 78), 0.3 mL Reverse primer (k 80), 0.25 mL RT
(reverse transcriptase), 10 mL extract, and 0.65 mL PCR grade water.
Real-time PCR was performed by using the Mx3000P Stratagene
real-time PCR system. The RT-PCR protocol included an RT (reverse
transcription) step for 30 min at 50 C and enzyme activation step
for 15 min at 95 C, followed by 40 cycles of denaturation (95 C for
15 s), annealing (55 C for 30 s), and extension (72 C for 30 s).
Single fluorescence detection was performed in each cycle at 72
C to reveal the positive samples. Melting curve analysis was done
immediately after the final amplification step by heating the sam-
ples at 95 C for 60 s, cooling to 55 C for 30 s, and heating to 95 C
for 30 s with continuous fluorescence recording. Melting curves
were recorded by plotting fluorescence signal intensity versus
temperature. The complete procedure included amplification, data
acquisition and analysis by Mxpro-mx3000 (year 2007).
The identity of some PCR products was investigated by 2.5%
agarose gel electrophoresis; to detect the characteristic band
(251 base pair) of the 50 un- translated region amplification.10,112.4. SYBR Green I based real time qualitative RT-PCR optimization
For optimization of the assay, we used the four standard HCV
copy DNA molecules with known viral loads (provided with the
HCV Qiagen kit TaqMan PCR Kit) which were processed by The
SYBR Green I PCR described and standard curve was plotted.
The maximum sensitivity was obtained by testing various
concentrations of primers. Optimal primer concentration was
determined by using samples with different primer concentrations
(0.1–0.5 mM). The amplification kit recruits TaqStart antibody that
prevents primer extension at sub-stringent temperatures
(HotStart) and minimize primer dimer formation.2.5. Sensitivity and specificity
In order to determine the analytical sensitivity of our assay,
RT-PCR experiments were performed on serial dilutions of stan-
dard copy DNA. To evaluate the specificity, known serum samples
negative for HCV were extracted and tested.3. Results
In this set of experiments, primer concentrations Ranging from
0.1 to 0.5 mM were tested. A primer concentration of 0.3 mM was
selected since it produced maximum amplification without primer
dimer formation. A MgCl2 concentration of 4 mM was used
throughout the study.
The dynamic range of our assay covered four orders of HCV viral
load from 102 to 106 IU/ml. HCV-specific fluorescent peaks were
detected in the positive serum samples and standard panel dilution
up to 50 IU/ml, but in none of the negative controls.
SYBR Green I fluorochrome binds to all amplicons without
distinguishing between HCV and non-HCV products. Thus, the
amplification product was characterized by melting curve analysis,
wherein the HCV amplicon was easily distinguishable by its speci-
fic Tm value.
Under the employed experimental conditions, while analyzing
the melting curve profiles of the PCR products, One of two different
melting curve peaks either at 82 C or 88 C were observed, and
both of them were associated with amplification plot (Fig. 1).
Fig. 1. Two cases detected positive by SYBR Green PCR method with two different melting curve peaks at 82 C and 88 C, respectively.
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region was carried out to verify that these curves were related to
the amplification of the specific target not the non-specific ones.
The characteristic band of 251 bp was obtained for both curves
indicating that the reason of obtaining two melting curves was
due to different GC content with the same amplicon size (Fig. 2).
Out of the 220 chronic HCV patients included in this study, 138
patients (62.7%) were males and 82 (37.3%) were females. Regard-
ing the associated risk factors, 77 cases (35%) had a history of hos-
pital admission and 30 (13.6%) had a history of blood transfusion.
Among the 220 studied subjects, HCV-RNA was detected in 156
cases (70.9%) by TaqMan probe technique, while 194 cases (88.2%)
were HCV-RNA positive by SYBR Green technique.
By both the techniques (TaqMan probe and SYBR Green), 154
(70%) were HCV-RNA positive and 24 (10.9%) were negative. On
the other hand 40 patients (18.2%) were HCV-RNA positive by SYBR
Green technique only and two (0.9%) by TaqMan probe only. Thus
SYBR Green technique has a sensitivity of 79.38%, specificity of
92.31%, positive predictive value of 98.72% and negative predictive
value of 37.50% Table 1 (see Figs. 3–5).
By SYBR Green technique, 70 (31.8%) of the 220 chronic HCV
patients showed a viral load equal or more than 106 IU/ml, 86
(39.1%) a viral load ranging from 104 to less than 106 IU/ml, and
38 (17.3%) with a viral load less than 104 IU/ml. On the other hand
HCV-RNA was not detected in 26 (11.8%) patients
Among the 156 chronic HCV patients positive by TaqMan probe
only 2 (1.3%) were negative by SYBR Green technique; in these two
cases, the viral load was very low (less than 104 IU/ml).Fig. 2. Agarose gel electrophoresis showing the characteristic band (251 base pair)
of 50 untranslated region amplification in two cases positive by SYBR Green with
two different melting curve peaks.4. Discussion
Egypt is facing a large burden of HCV disease, and prone to be
the most affected nation of the world. In Egypt, the HCV prevalence
and incidence across the diverse population groups are much
higher than those in other countries.12–14 This makes HCV and
the associated complications one of the leading public health con-
cerns that Egypt has to cope.15
The aim of this study was to compare between TaqMan probe
technique and SYBR Green method in diagnosis and follow up ofHCV patients. This study included 220 anti-HCV positive patients,
138 (62.7%) males and 82 (37.3%) females (male to female ratio:
1.75). In our patients, a history of blood transfusion was noted in
13.6% and hospital admission in 35%.
Fig. 4. Missed cases by SYBR Green technique when compared to TaqMan
technique.
Fig. 5. Missed cases by TaqMan technique when compared to SYBR green
technique.
Fig. 3. Differences between both SYBR Green and TaqMan probe techniques
regarding positivity and negativity.
Table 1
Sensitivity, specificity and accuracy of SYBR green assay in relation of TaqMan probe













Positive predictive value 98.72%
Negative predictive value 37.50%
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ficult to interpret, and prone to contamination.16 Recently, real-time
PCR has demonstrated its potential in detection of HCV RNA.9,16 The
advantages of this technique over conventional PCR include higher
sensitivity and specificity, accurate quantification, andmost impor-
tantly very low possibility of cross-contamination.17
SYBR Green is a fluorescent molecule that intercalates between
double-stranded DNA molecules. It has many advantages over
other real-time PCR detection methods, such as it is inexpensive
and technically simple to use.18 However, there is a major limita-
tion in SYBR Green real-time PCR, as the dye indiscriminately binds
to all double stranded DNA molecules resulting in non-specificity.
In this case, both nonspecific and the amplified products are
measured. Therefore, when SYBR Green is used, a melting-point
analysis is performed to distinguish amplified products from
others DNA molecules. The melting curve analysis identifies the
amplified product depending on its length and GC content.19In the current study, the existence of two peaks should corre-
spond to two amplified products. There are several situations
wherein two peaks can appear in real-time PCR dissociation curve,
e.g., non-specific amplifications, primer dimers and heterozygote
polymorphism.10 Conventional PCR targeting the 5́0 UTR region
was carried out to verify the identity of these curves. The charac-
teristic band of 251 bp was obtained for both curves indicating that
the reason of obtaining two melting curves was due to different GC
content with the same amplicon size The lower Tm belongs to a PCR
product having a lower GC content.11
Whereas, the labeled probes are expensive, add complexity to
the oligonucleotide design, and affect the parameters involved in
the classical amplification reaction.18 PCR artifacts may be noted,
especially when amplification cycles go above 30; besides this,
the selected target sequence may also undergo mutations. Such
mutations may render the target sequence undetectable by specific
probes (i.e., TaqMan).20 In SYBR Green-based methods such arti-
facts are easily recognized during melting curve analysis.19
Similar to our results, Shahzamani et al. and Schmittgen
et al.,21,22 reported a lower sensitivity of TaqMan probe technique
compared with the use of the fluorescence dye, SYBR Green I.
In the present study only two out of 196 HCV-RNA positive
cases were missed by SYBR Green Technique. Intermittent RNA
positivity was observed in samples with low levels of virus; this
could explain the two cases missed by SYBR Green technique.23
During optimization of the assay, we focused on the compatibil-
ity of oligonucleotide pairs during amplification and on minimizing
potential non-specific interactions such as primer dimers. In
particular, the determination of primer concentrations played a
pivotal role in enhancing the sensitivity and specificity. The SYBR
Green I real-time RT-PCR assay depends on melting curve analysis
to identify the target specifically. The Tm of the HCV melting curve
was 82 C with slight variations due to sequence variability
between the positive patients.
One of the advantages of this assay is its low cost.
5. Conclusion
we reveal in this study that combining Syber green amplifica-
tion (known with its high sensitivity) with melting curve analysis
to increase the specificity of the assay.
Besides offering good level of sensitivity and specificity, rela-
tively low cost, and low contamination rate, SYBR Green assay is
perfectly suitable for both routine clinical use and large-scale
screening of donated blood.
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Green assay for application as a screening assay for blood banking.
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